Works matching IS 13518216 AND DT 2004 AND VI 10 AND IP 5

Results: 33

HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 509, doi. 10.1111/j.1365-2516.2004.01011.x

By:

Bril, W. S.;
P. E. Maclean;
P. H. P. Kaijen;
van den Brink, E. N.;
Lardy, N. M.;
K. Fijnvandraat;
M. Peters;
Voorberg, J.

Publication type:

Article

Severe factor X deficiency in pregnancy: case report and review of the literature.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 665, doi. 10.1111/j.1365-2516.2004.01012.x

By:

Romagnolo, C.;
Burati, S.;
Ciaffoni, S.;
Fattori, E.;
Franchi, M.;
Zanon, E.;
Girolami, A.

Publication type:

Article

Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 452, doi. 10.1111/j.1365-2516.2004.01013.x

By:

Stieltjes, N.;
Altisent, C.;
Auerswald, G.;
Négrier, C.;
Pouzol, P.;
Reynaud, J.;
Roussel-Robert, V.;
Savidge, G. F.;
Villar, A.;
Schulman, S.

Publication type:

Article

Acquired inhibitor of factor V: first report in China and literature review.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 661, doi. 10.1111/j.1365-2516.2004.01014.x

By:

Lu, L.;
Liu, Y.;
Wei, J.;
Zhang, L.;
Yang, R.

Publication type:

Article

Functional consequences of haemophilia in adults: the development of the Haemophilia Activities List.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 565, doi. 10.1111/j.1365-2516.2004.01016.x

By:

van Genderen, F. R.;
van Meeteren, N. L. U.;
van der Bom, J. G.;
Heijnen, L.;
de Kleijn, P.;
van den Berg, H. M.;
Helders, P. J. M.

Publication type:

Article

Factors which may influence coping with disease in haemophilia patients.

Published in:

2004

By:

Canclini, M.;
Zanon, E.;
Girolami, A.

Publication type:

Letter

Yttrium.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 590, doi. 10.1111/j.1365-2516.2004.01035.x

By:

Helm, M.;
Tiktinsky, R.;
Amit, Y.;
Martinowitz, U.

Publication type:

Article

Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate®): a prospective pharmacovigilance study.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 491, doi. 10.1111/j.1365-2516.2004.00904.x

By:

Ewenstein, B. M.;
Gomperts, E. D.;
Pearson, S.;
O'Banion, M. E.

Publication type:

Article

Successful use of ReFacto continuous infusion in two paediatric patients with severe haemophilia A undergoing orthopaedic surgery.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 655, doi. 10.1111/j.1365-2516.2004.00905.x

By:

Sennett, M. M.;
de Alarcón, P. A.

Publication type:

Article

Informativeness of linkage analysis for genetic diagnosis of haemophilia A in India.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 553, doi. 10.1111/j.1365-2516.2004.00908.x

By:

Jayandharan, G.;
Shaji, R. V.;
George, B.;
Chandy, M.;
Srivastava, A.

Publication type:

Article

Radiation synovectomy by188Re-Sulfide in haemophilic synovitis.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 422, doi. 10.1111/j.1365-2516.2004.00913.x

By:

Li, P.;
Chen, G.;
Zhang, H.;
Shen, Z.

Publication type:

Article

Haemostatic management of intraoral bleeding in patients with congenital deficiency ofα2-plasmin inhibitor or plasminogen activator inhibitor-1.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 669, doi. 10.1111/j.1365-2516.2004.00914.x

By:

Morimoto, Y.;
Yoshioka, A.;
Imai, Y.;
Takahashi, Y.;
Minowa, H.;
Kirita, T.

Publication type:

Article

Endometrial ablation for von Willebrand disease-related menorrhagia– experience with seven cases.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 477, doi. 10.1111/j.1365-2516.2004.00915.x

By:

Rubin, G.;
Wortmant, M.;
Kouides, P. A.

Publication type:

Article

Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 413, doi. 10.1111/j.1365-2516.2004.00919.x

By:

Theodore, D.;
Fried, M. W.;
Kleiner, D. E.;
Kroner, B. L.;
Goedert, J. J.;
Eyster, M. E.;
Faust, S. P.;
Sherman, K. E.;
Kessler, C. M.;
Francis, C.;
Aledort, L. M.

Publication type:

Article

Shoulder hemiarthroplasty to manage haemophilic arthropathy: two case studies.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 649, doi. 10.1111/j.1365-2516.2004.00923.x

By:

Dalzell, R.

Publication type:

Article

Survival analysis of patients with haemophilia at the International Haemophilia Training Centre, Bangkok, Thailand.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 542, doi. 10.1111/j.1365-2516.2004.00928.x

By:

Chuansumrit, A.;
Krasaesub, S.;
Angchaisuksiri, P.;
Hathirat, P.;
Isarangkura, P.

Publication type:

Article

Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 572, doi. 10.1111/j.1365-2516.2004.00930.x

By:

Magli-Barioz, D.;
Ounnoughène, N.;
Paugy, P.;
Quarrè, M.-C.;
Vassilief, D.;
Lopez, I.;
Goudemand, J.;
Negrier, C.;
Assogba, U.;
Driss, F.;
A.-Dumont, M.;
Molho, P.

Publication type:

Article

Increased breakthrough bleeding during prophylaxis with B-domain deleted factor VIII– a robust meta-analytic finding.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 449, doi. 10.1111/j.1365-2516.2004.00931.x

By:

Gruppo, R. A;
Brown, D.;
Wilkes, M. M.;
Navickis, R. J.

Publication type:

Article

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 428, doi. 10.1111/j.1365-2516.2004.00932.x

By:

Tarantino, M. D.;
Collins, P. W.;
Hay, C. R. M.;
Shapiro, A. D.;
Gruppo, R. A.;
Berntorp, E.;
Bray, G. L.;
Tonetta, S. A.;
Schroth, P. C.;
Retzios, A. D.;
Rogy, S. S.;
Sensel, M. G.;
Ewenstein, B. M.

Publication type:

Article

Consensus recommendations for use of central venous access devices in haemophilia.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 629, doi. 10.1111/j.1365-2516.2004.00943.x

By:

Ewenstein, B. M.;
Valentino, L. A.;
Journeycake, J. M.;
Tarantino, M. D.;
Shapiro, A. D.;
Blanchette, V. S.;
Hoots, W. K.;
Buchanan, G. R.;
Manco-Johnson, M. J.;
Rivard, G. -E.;
Miller, K. L.;
Geraghty, S.;
Maahs, J. A.;
Stuart, R.;
Dunham, T.;
Navickis, R. J.

Publication type:

Article

The rare coagulation disorders– review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 593, doi. 10.1111/j.1365-2516.2004.00944.x

By:

Bolton-Maggs, P. H. B.;
Perry, D. J.;
Chalmers, E. A.;
Parapia, L. A.;
Wilde, J. T.;
Williams, M. D.;
Collins, P. W.;
Kitchen, S.;
Dolan, G.;
Mumford, A. D.

Publication type:

Article

Clinical manifestations and management of labor and delivery in women with factor IX deficiency.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 483, doi. 10.1111/j.1365-2516.2004.00946.x

By:

Yang, M. Y.;
Ragni, M. V.

Publication type:

Article

Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 438, doi. 10.1111/j.1365-2516.2004.00947.x

By:

Wolf, D. M.;
Rokicka-Milewska, R.;
Lopaciuk, S.;
Skotnicki, A. B.;
Klukowska, A.;
Laguna, P.;
Windyga, J.;
Kotitschke, R.;
Struff, W. G.

Publication type:

Article

Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B– Factor IXDelhi.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 550, doi. 10.1111/j.1365-2516.2004.00948.x

By:

Mahajan, A.;
Sharma, A.;
Chavali, S.;
Kabra, M.;
Chowdhury, M. R.;
Srinivasan, N.;
D. Bharadwaj

Publication type:

Article

Comparative effectiveness of plasma-derived and recombinant FVIII concentrates in the on-demand and prophylactic treatment of patients with haemophilia A.

Published in:

2004

By:

Pollmann, H.;
Richter, H.;
Siegmund, B.

Publication type:

Letter

Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 499, doi. 10.1111/j.1365-2516.2004.00950.x

By:

Auerswald, G.;
Prondzinski, M. Von Depka;
Ehlken, B.;
Kreuz, W.;
Kurnik, K.;
Lenk, H.;
Scharrer, I.;
Schramm, W.;
Zimmermann, R.

Publication type:

Article

Asking fathers: a study of psychosocial adaptation.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 582, doi. 10.1111/j.1365-2516.2004.00958.x

By:

Herrick, E. K.;
Nussbaum, R.;
Holtzman, N. A.;
Wissow, L.

Publication type:

Article

Factor XIII deficiency in south-east Iran.

Published in:

2004

By:

Eshghi, P.;
Abolghasemi, H.;
Sanei-Moghaddam, E.;
Anwar, R.;
Jazebi, M.;
Amid, A.;
Alatt, F. A.

Publication type:

Letter

Type 2N von Willebrand disease mutations in Brazilian individuals.

Published in:

2004

By:

Simon, D.;
Roisenberg, I.

Publication type:

Letter

Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 527, doi. 10.1111/j.1365-2516.2004.00954.x

By:

Carlsson, K. Steen;
Höjgård, S.;
Lethagen, S.;
Lindgren, A.;
Berntorp, E.;
Lindgren, B.

Publication type:

Article

Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 459, doi. 10.1111/j.1365-2516.2004.00957.x

By:

Lin, Y.;
Yang, X.;
Chevrier, M. -C.;
Craven, S.;
Barrowcliffe, T. W.;
Lemieux, R.;
Ofosu, F. A.

Publication type:

Article

Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 515, doi. 10.1111/j.1365-2516.2004.00952.x

By:

Carlsson, K. Steen;
Höjgard, S.;
Lindgren, A.;
Lethagen, S.;
Schulman, S.;
Glomstein, A.;
Tengborn, L.;
Berntorp, E.;
Lindgren, B.

Publication type:

Article

The impact of unaware carriership on the clinical presentation of haemophilia.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 560, doi. 10.1111/j.1365-2516.2004.00955.x

By:

MaClean, P. E.;
Fijnvandraat, K.;
Beijlevelt, M.;
Peters, M.

Publication type:

Article

Works matching IS 13518216 AND DT 2004 AND VI 10 AND IP 5

HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg<sup>593</sup> to Cys mutation.

Severe factor X deficiency in pregnancy: case report and review of the literature.

Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience.

Acquired inhibitor of factor V: first report in China and literature review.

Functional consequences of haemophilia in adults: the development of the Haemophilia Activities List.

Factors which may influence coping with disease in haemophilia patients.

Yttrium.

Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate<sup>®</sup>): a prospective pharmacovigilance study.

Successful use of ReFacto continuous infusion in two paediatric patients with severe haemophilia A undergoing orthopaedic surgery.

Informativeness of linkage analysis for genetic diagnosis of haemophilia A in India.

Radiation synovectomy by<sup>188</sup>Re-Sulfide in haemophilic synovitis.

Haemostatic management of intraoral bleeding in patients with congenital deficiency ofα2-plasmin inhibitor or plasminogen activator inhibitor-1.

Endometrial ablation for von Willebrand disease-related menorrhagia– experience with seven cases.

Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C.

Shoulder hemiarthroplasty to manage haemophilic arthropathy: two case studies.

Survival analysis of patients with haemophilia at the International Haemophilia Training Centre, Bangkok, Thailand.

Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications.

Increased breakthrough bleeding during prophylaxis with B-domain deleted factor VIII– a robust meta-analytic finding.

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.

Consensus recommendations for use of central venous access devices in haemophilia.

The rare coagulation disorders– review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.

Clinical manifestations and management of labor and delivery in women with factor IX deficiency.

Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin<sup>®</sup> SDH in previously treated patients with severe haemophilia A.

Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B– Factor IX<sub>Delhi</sub>.

Comparative effectiveness of plasma-derived and recombinant FVIII concentrates in the on-demand and prophylactic treatment of patients with haemophilia A.

Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany.

Asking fathers: a study of psychosocial adaptation.

Factor XIII deficiency in south-east Iran.

Type 2N von Willebrand disease mutations in Brazilian individuals.

Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.

Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.

Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.

The impact of unaware carriership on the clinical presentation of haemophilia.